Efficacy and safety of biosimilar ABP 980 compared with trastuzumab in HER2 positive early breast cancer

Authors :: Vladimir Hanes
O. Ponomarova
Serafin Morales
G. von Minckwitz
N. Zhang
Source :: Annals of Oncology. 28:v44
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
030219 obstetrics & reproductive medicine
business.industry
Biosimilar
Hematology
03 medical and health sciences
0302 clinical medicine
Biosimilar Pharmaceuticals
Trastuzumab
030220 oncology & carcinogenesis
Internal medicine
medicine
business
Early breast cancer
medicine.drug

Full Text Access

Tools